A recent collaboration between Belgian pharmaceutical group UCB and France-based Oncodesign aims at the development of innovative therapeutic treatments in neurodegenerative diseases. Within the framework of this collaboration, Oncodesign will apply its Nanocyclix technology* to identify next generation kinase inhibitors [...]
An article in the Japanese press is praising the quality of research in cellular therapy at the UCL within the laboratory of Prof. Etienne Sokal and at Louvain-born spin-off Promethera Biosciences. The article on regenerative medicine, [...]